Vaccination has more to offer than direct clinical benefit: FDA's vaccine licensure process ignores population health and social determinants of disease
Description
The current U.S. Food and Drug Administration (FDA) licensure process underestimates the potential benefits of vaccines at both the individual and population levels by considering only direct clinical outcomes of vaccination. While all approved
